BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Treatment
116 results:

  • 1. Epidemiology of and Risk Factors in Postoperative Complications from Robotically Assisted Laparoscopic Radical prostatectomy in Contemporary National Surgical Quality Improvement Program Data.
    Homer A; Golijanin B; Schmitt P; Bhatt V; Pareek G; Hyams ES
    J Endourol; 2024 Mar; 38(3):270-275. PubMed ID: 38251639
    [No Abstract]    [Full Text] [Related]  

  • 2. Global viewpoints: updates on prostate cancer in Sub-Saharan Africa.
    Jalloh M; Cassell A; Niang L; Rebbeck T
    BJU Int; 2024 Jan; 133(1):6-13. PubMed ID: 37702258
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Acceptability of a shared cancer follow-up model of care between general practitioners and radiation oncologists: A qualitative evaluation.
    Sandell T; Schütze H; Miller A
    Health Expect; 2023 Dec; 26(6):2441-2452. PubMed ID: 37583292
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Impact of Medicare Low-income Subsidy on Access to treatment, treatment Choice, and Oncologic Outcomes in Patients With Metastatic prostate cancer.
    Joyce DD; Qin X; Sharma V; Boorjian SA; Barocas DA; Dusetzina SB; Moses KA
    J Urol; 2023 Sep; 210(3):447-453. PubMed ID: 37341420
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Narrative Synthesis of Literature on the Barriers to Timely Diagnosis and treatment of cancer in Sub-Saharan Africa.
    Mwamba M; Lombe DC; Msadabwe S; Bond V; Simwinga M; Sentoogo Ssemata A; Muhumuza R; Seeley J; Mwaka AD; Aggarwal A
    Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e537-e548. PubMed ID: 37302880
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.
    Davies L; Milner DA; Shulman LN; Kyokunda L; Bedada A; Vuylsteke P; Masalu N; Jackson P; Jennings N; Odunlami A; Mtshali P; Dugan U
    JCO Glob Oncol; 2023 Jun; 9():e2200203. PubMed ID: 37290022
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for prostate cancer, 2002-2015.
    Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
    JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Benchmarking the Radiation Oncology Alternative Payment Model: Changes in Medicare Reimbursement for 16 Common Radiation Therapy treatment Courses.
    Hogan JS; Karraker P; Fischer-Valuck BW; Vapiwala N; Mehta MP; Perez CA; Baumann JC; Bradley JD; Baumann BC
    Pract Radiat Oncol; 2023; 13(5):e389-e394. PubMed ID: 37172757
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
    Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.
    Roy S; Wallis CJD; Morgan SC; Kishan AU; Le ATT; Malone J; Sun Y; Spratt DE; Saad F; Malone S
    Prostate; 2023 Jul; 83(10):912-921. PubMed ID: 37071764
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort.
    Palm A; Theorell-Haglöw J; Isakson J; Ljunggren M; Sundh J; Ekström MP; Grote L
    BMJ Open; 2023 Mar; 13(3):e064501. PubMed ID: 36868588
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Consensus Quality Measures and Dose Constraints for prostate cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
    Solanki AA; Puckett LL; Kujundzic K; Katsoulakis E; Park J; Kapoor R; Hagan M; Kelly M; Palta J; Ballas LK; DeMarco J; Hoffman KE; Lawton CAF; Michalski J; Potters L; Zelefsky M; Kudner R; Dawes S; Wilson E; Sandler H
    Pract Radiat Oncol; 2023; 13(2):e149-e165. PubMed ID: 36522277
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy.
    Feng J; Xi Z; Jiang X; Li Y; Nik Nabil WN; Liu M; Song Z; Chen X; Zhou H; Dong Q; Xu H
    Cancer Lett; 2023 Feb; 554():216011. PubMed ID: 36442771
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiation Therapy Expenditures Through the First 8 Performance Periods of the Oncology Care Model at a Statewide Multispecialty Health System.
    De B; Andres G; Bates C; Staren E; Kutscher E; Brooks DJ; Thaker GH; Buscema J; Gin R; Thaker N
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):491-499. PubMed ID: 36427644
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Reirradiation Options for Previously Irradiated prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT).
    Zhong J; Brown S; Serra M; Shuttleworth P; Bownes P; Thompson C; Reed R; Reeves K; Dubec M; McHugh D; Eccles C; Chuter R; Tsang YM; Taylor NJ; West C; Buckley D; Scarsbrook A; Choudhury A; Hoskin P; Henry A
    BMJ Open; 2022 Nov; 12(11):e068580. PubMed ID: 36351720
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Access to and Affordability of World Health Organization Essential Medicines for cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
    Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
    Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Choosing Wisely Africa: Insights from the front lines of clinical care.
    Rubagumya F; Makori K; Borges H; Mwanzi S; Karim S; Msadabwe C; Dharsee N; Mutebi M; Hopman WM; Vanderpuye V; Ka S; Ndlovu N; Hammad N; Booth CM
    J Cancer Policy; 2022 Sep; 33():100348. PubMed ID: 35872184
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805.
    Morgans AK; Chen YH; Jarrard DF; Carducci M; Liu G; Eisenberger M; Plimack ER; Bryce A; Garcia JA; Dreicer R; Vogelzang NJ; Picus J; Shevrin D; Hussain M; DiPaola RS; Cella D; Sweeney CJ;
    Prostate; 2022 Sep; 82(12):1176-1185. PubMed ID: 35538398
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Effects of systemic anti-androgen drugs on the ocular surface.
    Aydin Kurna S; Oflaz Hacisalihoglu A; Altun A; Ozbay Ozel N; Uruc F; Kanar HS; Karatay Arsan A
    J Fr Ophtalmol; 2022 Jun; 45(6):619-627. PubMed ID: 35489988
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Registration of trans-perineal template mapping biopsy cores to volumetric ultrasound.
    Aleef TA; Zeng Q; Morris WJ; Mahdavi SS; Salcudean SE
    Int J Comput Assist Radiol Surg; 2022 May; 17(5):929-936. PubMed ID: 35380340
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.